Teva Pharmaceuticals USA, Inc recalls Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx o
Recalled November 12, 2025 · FDA recall D-0151-2026 · Teva Pharmaceuticals USA
Hazard
Subpotent drug; Clavulanate Potassium component · FDA Class II
Units
4680 cartons
Sold at
Distributed in three (3) States: MS, OH, CA.
Description
Subpotent drug; Clavulanate Potassium component
Product
Amoxicillin and Clavulanate Potassium for Oral Suspension USP, 200 mg/28.5 mg per 5mL, 100 mL (when reconstituted), Rx only, manufactured in Canada by: Teva Canada Limited, Toronto, Canada M1B 2K9; Manufactured For: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054 NDC 0093-2277-7.
Manufacturer(s)
Teva Pharmaceuticals USA, Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →